Subhankar Chakraborty Selected Research

Subhankar Chakraborty Research Topics

Disease

20	Neoplasms (Cancer) 07/2016 - 04/2007
12	Pancreatic Neoplasms (Pancreatic Cancer) 08/2013 - 04/2008
7	Neoplasm Metastasis (Metastasis) 07/2016 - 04/2007
4	Adenocarcinoma 06/2011 - 04/2007
3	Dyspepsia (Indigestion) 04/2024 - 10/2019
3	Constipation 01/2019 - 01/2016
3	Inflammation (Inflammations) 01/2016 - 02/2011
3	Pancreatitis 01/2011 - 03/2008
2	Gastroparesis 04/2024 - 01/2019
2	Ulcer 01/2020 - 10/2019
2	Breast Neoplasms (Breast Cancer) 01/2013 - 04/2011
2	Skin Diseases (Skin Disease) 02/2011 - 07/2010
1	Nausea 04/2024
1	Fecal Incontinence 10/2023
1	Weight Gain 09/2023
1	Diabetes Mellitus 01/2019
1	Fibrosis (Cirrhosis) 07/2016
1	Thrombosis (Thrombus) 07/2016
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 07/2016
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2016
1	Diarrhea 01/2016
1	Abdominal Pain (Pain, Abdominal) 01/2016
1	Coma (Comas) 12/2014
1	Myxedema 12/2014
1	Osteomyelitis 05/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014
1	Encephalitis (Encephalitis, Rasmussen) 08/2013
1	Chronic Pancreatitis 04/2013
1	Pancreatic Diseases (Pancreatic Disease) 04/2013
1	Second Primary Neoplasms (Neoplasms, Second) 04/2013
1	Triple Negative Breast Neoplasms 01/2013
1	Carcinogenesis 01/2013
1	Multiple Myeloma 10/2012
1	Ulcerative Colitis 01/2012
1	Circulating Neoplastic Cells 01/2011
1	Ovarian Neoplasms (Ovarian Cancer) 01/2011
1	Lymphoid Leukemia 01/2011
1	Infections 01/2011
1	Progressive Multifocal Leukoencephalopathy 01/2011
1	Lung Neoplasms (Lung Cancer) 08/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2010

Drug/Important Bio-Agent (IBA)

11	MucinsIBA 01/2014 - 04/2007
7	Biomarkers (Surrogate Marker)IBA 01/2013 - 08/2008
4	Proteins (Proteins, Gene)FDA Link 07/2016 - 03/2008
4	Lipocalin-2IBA 04/2013 - 09/2010
4	Glycoproteins (Glycoprotein)IBA 02/2011 - 04/2008
3	LipidsIBA 04/2024 - 01/2019
3	Cadherins (E-Cadherin)IBA 08/2013 - 04/2007
2	AntibodiesIBA 01/2011 - 08/2008
1	Clonidine (ST 155)FDA LinkGeneric 10/2023
1	Colesevelam Hydrochloride (Welchol)FDA Link 10/2023
1	Proton Pump InhibitorsIBA 09/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019
1	exendin (9-39)IBA 01/2019
1	alfuzosin (UroXatral)FDA Link 01/2019
1	Cysteine (L-Cysteine)FDA Link 07/2016
1	pirfenidoneIBA 07/2016
1	AntioxidantsIBA 07/2016
1	Disulfiram (Antabuse)FDA Link 07/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Opioid Analgesics (Opioids)IBA 01/2016
1	Amiodarone (Amiodarona)FDA LinkGeneric 12/2014
1	Doxycycline (Periostat)FDA LinkGeneric 05/2014
1	Secretin FDA Link 04/2013
1	Growth Differentiation Factor 15IBA 04/2013
1	CarbohydratesIBA 04/2013
1	AntigensIBA 04/2013
1	human RCC1 proteinIBA 11/2012
1	Glucose (Dextrose)FDA LinkGeneric 11/2012
1	Adenosine Triphosphate (ATP)IBA 11/2012
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 11/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2012
1	Epidermal Growth Factor (EGF)IBA 06/2011
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2011
1	Polysaccharides (Glycans)IBA 01/2011
1	Galectins (Galectin)IBA 01/2011
1	Galectin 3 (LGALS3)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	EnzymesIBA 01/2011
1	Rituximab (Mabthera)FDA Link 01/2011
1	ImmunosorbentsIBA 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Estrogen Receptor betaIBA 08/2010
1	Estrogens (Estrogen)FDA Link 08/2010
1	Estrogen Receptor alphaIBA 08/2010
1	Estrogen ReceptorsIBA 08/2010
1	p38 Mitogen-Activated Protein KinasesIBA 05/2010

Therapy/Procedure

11	Therapeutics 07/2016 - 08/2008
3	Radiotherapy 04/2013 - 01/2011
2	Drug Therapy (Chemotherapy) 01/2016 - 01/2011
1	Electroacupuncture 12/2016
1	Central Venous Catheters 07/2016
1	Pain Management 01/2016
1	Complementary Therapies (Alternative Medicine) 08/2013
1	Cranial Irradiation 08/2013
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 08/2010